181 related articles for article (PubMed ID: 10414400)
1. Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome.
Sallenave JM; Donnelly SC; Grant IS; Robertson C; Gauldie J; Haslett C
Eur Respir J; 1999 May; 13(5):1029-36. PubMed ID: 10414400
[TBL] [Abstract][Full Text] [Related]
2. Elafin/elastase-specific inhibitor in bronchoalveolar lavage of normal subjects and farmer's lung.
Tremblay GM; Sallenave JM; Israél-Assayag E; Cormier Y; Gauldie J
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):1092-8. PubMed ID: 8887613
[TBL] [Abstract][Full Text] [Related]
3. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
4. Studies on the pathogenesis of the adult respiratory distress syndrome.
McGuire WW; Spragg RG; Cohen AB; Cochrane CG
J Clin Invest; 1982 Mar; 69(3):543-53. PubMed ID: 7037851
[TBL] [Abstract][Full Text] [Related]
5. Secretory leukocyte proteinase inhibitor, alpha-1-antitrypsin deficiency and emphysema: Preliminary study, speculation and an hypothesis.
Ayad MS; Knight KR; Burdon JG; Brenton S
Respirology; 2003 Jun; 8(2):175-80. PubMed ID: 12753532
[TBL] [Abstract][Full Text] [Related]
6. Effect of fluticasone on the elastase:antielastase profile of the normal lung.
Kamal AM; Corrigan CJ; Tetley TD; Alaghband-Zadeh J; Smith SF
Eur J Clin Invest; 2002 Sep; 32(9):713-9. PubMed ID: 12486873
[TBL] [Abstract][Full Text] [Related]
7. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors.
Bergenfeldt M; Axelsson L; Ohlsson K
Scand J Clin Lab Invest; 1992 Dec; 52(8):823-9. PubMed ID: 1362620
[TBL] [Abstract][Full Text] [Related]
8. The effect of immediate-hypersensitivity reactions on the level of SLPI, granulocyte elastase, alpha1-antitrypsin, and albumin in nasal secretions, by the method of unilateral antigen challenge.
Westin U; Lundberg E; Wihl JA; Ohlsson K
Allergy; 1999 Aug; 54(8):857-64. PubMed ID: 10485390
[TBL] [Abstract][Full Text] [Related]
9. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
[TBL] [Abstract][Full Text] [Related]
10. Proteinase-antiproteinase balance in tracheal aspirates from neonates.
Sluis KB; Darlow BA; Vissers MC; Winterbourn CC
Eur Respir J; 1994 Feb; 7(2):251-9. PubMed ID: 7909297
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil DNA contributes to the antielastase barrier during acute lung inflammation.
Balloy V; Sallenave JM; Crestani B; Dehoux M; Chignard M
Am J Respir Cell Mol Biol; 2003 Jun; 28(6):746-53. PubMed ID: 12600833
[TBL] [Abstract][Full Text] [Related]
12. [Activation of granulocytes and antiproteases in open heart surgery].
Welters ID; Hirsch J; Menzebach A; Hempelmann G; Müller M
Anasthesiol Intensivmed Notfallmed Schmerzther; 2005 Mar; 40(3):164-72. PubMed ID: 15770560
[TBL] [Abstract][Full Text] [Related]
13. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
[TBL] [Abstract][Full Text] [Related]
14. Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases.
Kouchi I; Yasuoka S; Ueda Y; Ogura T
Tokushima J Exp Med; 1993 Jun; 40(1-2):95-107. PubMed ID: 8105562
[TBL] [Abstract][Full Text] [Related]
15. Plasma neutrophil elastase and elafin imbalance is associated with acute respiratory distress syndrome (ARDS) development.
Wang Z; Chen F; Zhai R; Zhang L; Su L; Lin X; Thompson T; Christiani DC
PLoS One; 2009; 4(2):e4380. PubMed ID: 19197381
[TBL] [Abstract][Full Text] [Related]
16. Bronchiolitis obliterans syndrome after (heart-)lung transplantation. Impaired antiprotease defense and increased oxidant activity.
Hirsch J; Elssner A; Mazur G; Maier KL; Bittmann I; Behr J; Schwaiblmair M; Reichenspurner H; Fürst H; Briegel J; Vogelmeier C
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1640-6. PubMed ID: 10556134
[TBL] [Abstract][Full Text] [Related]
17. Contribution of secretory leukocyte proteinase inhibitor to the antiprotease defense system of the peripheral lung: effect of ozone-induced acute inflammation.
Nadziejko C; Finkelstein I; Balmes JR
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1592-8. PubMed ID: 7582300
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant and antiprotease status in peripheral blood and BAL fluid after cardiopulmonary bypass.
Frass OM; Bühling F; Täger M; Frass H; Ansorge S; Huth C; Welte T
Chest; 2001 Nov; 120(5):1599-608. PubMed ID: 11713141
[TBL] [Abstract][Full Text] [Related]
19. Interaction of secretory leukocyte protease inhibitor with proteinase-3.
Rao NV; Marshall BC; Gray BH; Hoidal JR
Am J Respir Cell Mol Biol; 1993 Jun; 8(6):612-6. PubMed ID: 8100709
[TBL] [Abstract][Full Text] [Related]
20. Comparative loss of activity of recombinant secretory leukoprotease inhibitor and alpha 1-protease inhibitor caused by different forms of oxidative stress.
Vogelmeier C; Biedermann T; Maier K; Mazur G; Behr J; Krombach F; Buhl R
Eur Respir J; 1997 Sep; 10(9):2114-9. PubMed ID: 9311513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
